NIH Clinical Center: Search the Studies

Search the Studies

7 Studies found from all possible combinations of your search terms. Select a protocol that you wish to review.

Protocol Number	Title	Protocol Status	Min-Max Age	Institute	Keywords
001631-I	An Exploratory Study of The Effect of Bismuth Subsalicylate on The Gut Microbiome and Host Response in Healthy Adults	Participants currently recruited/enrolled	18-50 Years	NIAID	Diarrhea
20-I-0088	An Open-label Efficacy and Safety Study of Pozelimab in Patients with CD55 deficient Protein-losing Enteropathy (CHAPLE Disease)	No longer recruiting/follow-up only	3-100 Years	NIAID	Diarrhea
20-DK-0018	Prebiotics and Metformin Influences Gut and Hormones in Type 2 Diabetes Youth	Completed Study; data analyses ongoing	10-25 Years	NIDDK	Diarrhea
19-C-0061	A Phase 2 Trial of the MEK Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate) in Combination with the mTOR Inhibitor Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors	Completed Study; data analyses ongoing	12-125 Years	NCI	Diarrhea
17-I-0101	An Open-Label, Proof of Concept Study of Vorinostat for the Treatment of Moderate-to-Severe Crohn's Disease and Maintenance Therapy with Ustekinumab	Participants currently recruited/enrolled	18-65 Years	NIAID	Diarrhea
17-C-0009	Phase I Trial of Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide (tmz) Followed by Randomized Phase II Trial of Zotiraciclib (TG02) plus Temozolomide versus Temozolomide alone in Adults with Recurrent Anaplastic Astrocytoma and Glioblastom	Completed Study; data analyses ongoing	18-125 Years	NCI	Diarrhea
15-C-0145	Phase I/II Study of the Anti-Programmed Death Ligand-1 Antibody Durvalumab (MEDI4736) in Combination with Olaparib and/or Cediranib for Advanced Solid Tumors and Advanced or Recurrent Ovarian, Triple Negative Breast, Lung, Prostate and Colorectal Cancers	Participants currently recruited/enrolled	18-125 Years	NCI	Diarrhea